Literature DB >> 27048650

Cysteine S-Glutathionylation Promotes Stability and Activation of the Hippo Downstream Effector Transcriptional Co-activator with PDZ-binding Motif (TAZ).

Rajesh Kumar Gandhirajan1, Manaswita Jain1, Benedikt Walla1, Marc Johnsen1, Malte P Bartram1, Minh Huynh Anh1, Markus M Rinschen1, Thomas Benzing2, Bernhard Schermer3.   

Abstract

Transcriptional co-activator with PDZ-binding motif (TAZ) and Yes-associated protein (YAP) are critical transcriptional co-activators downstream of the Hippo pathway involved in the regulation of organ size, tissue regeneration, proliferation, and apoptosis. Recent studies suggested common and distinct functions of TAZ and YAP and their diverse impact under several pathological conditions. Here we report differential regulation of TAZ and YAP in response to oxidative stress. H2O2 exposure leads to increased stability and activation of TAZ but not of YAP. H2O2 induces reversible S-glutathionylation at conserved cysteine residues within TAZ. We further demonstrate that TAZ S-glutathionylation is critical for reactive oxygen species (ROS)-mediated, TAZ-dependent TEA domain transcription factor (TEAD) trans-activation. Lysophosphatidic acid, a physiological activator of YAP and TAZ, induces ROS elevation and, subsequently, TAZ S-glutathionylation, which promotes TAZ-mediated target gene expression. TAZ expression is essential for renal homeostasis in mice, and we identify basal TAZ S-glutathionylation in murine kidney lysates, which is elevated during ischemia/reperfusion injury in vivo This induced nuclear localization of TAZ and increased expression of connective tissue growth factor. These results describe a novel mechanism by which ROS sustains total cellular levels of TAZ. This preferential regulation suggests TAZ to be a redox sensor of the Hippo pathway.
© 2016 by The American Society for Biochemistry and Molecular Biology, Inc.

Entities:  

Keywords:  Hippo pathway; S-glutathionylation; Yes-associated protein (YAP); connective tissue growth factor (CTGF); oxidative stress; reactive oxygen species (ROS); transcriptional co-activator with PDZ-binding motif (TAZ)

Mesh:

Substances:

Year:  2016        PMID: 27048650      PMCID: PMC4882430          DOI: 10.1074/jbc.M115.712539

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  42 in total

Review 1.  NOX enzymes and the biology of reactive oxygen.

Authors:  J David Lambeth
Journal:  Nat Rev Immunol       Date:  2004-03       Impact factor: 53.106

2.  A conserved MST-FOXO signaling pathway mediates oxidative-stress responses and extends life span.

Authors:  Maria K Lehtinen; Zengqiang Yuan; Peter R Boag; Yue Yang; Judit Villén; Esther B E Becker; Sara DiBacco; Núria de la Iglesia; Steven Gygi; T Keith Blackwell; Azad Bonni
Journal:  Cell       Date:  2006-06-02       Impact factor: 41.582

Review 3.  G-protein-coupled receptors and cancer.

Authors:  Robert T Dorsam; J Silvio Gutkind
Journal:  Nat Rev Cancer       Date:  2007-02       Impact factor: 60.716

4.  Dynamic redox control of NF-kappaB through glutaredoxin-regulated S-glutathionylation of inhibitory kappaB kinase beta.

Authors:  Niki L Reynaert; Albert van der Vliet; Amy S Guala; Toby McGovern; Milena Hristova; Cristen Pantano; Nicholas H Heintz; John Heim; Ye-Shih Ho; Dwight E Matthews; Emiel F M Wouters; Yvonne M W Janssen-Heininger
Journal:  Proc Natl Acad Sci U S A       Date:  2006-08-17       Impact factor: 11.205

5.  Relationship between the occurrence of cysteine in proteins and the complexity of organisms.

Authors:  A Miseta; P Csutora
Journal:  Mol Biol Evol       Date:  2000-08       Impact factor: 16.240

6.  G protein-coupled lysophosphatidic acid receptors stimulate proliferation of colon cancer cells through the {beta}-catenin pathway.

Authors:  Ming Yang; Wendy W Zhong; Neelam Srivastava; Anthony Slavin; Jianxin Yang; Timothy Hoey; Songzhu An
Journal:  Proc Natl Acad Sci U S A       Date:  2005-04-18       Impact factor: 11.205

7.  Defects in yolk sac vasculogenesis, chorioallantoic fusion, and embryonic axis elongation in mice with targeted disruption of Yap65.

Authors:  Elizabeth M Morin-Kensicki; Brian N Boone; Michael Howell; Jaclyn R Stonebraker; Jeremy Teed; James G Alb; Terry R Magnuson; Wanda O'Neal; Sharon L Milgram
Journal:  Mol Cell Biol       Date:  2006-01       Impact factor: 4.272

8.  Selective blockade of lysophosphatidic acid LPA3 receptors reduces murine renal ischemia-reperfusion injury.

Authors:  Mark D Okusa; Hong Ye; Liping Huang; Laura Sigismund; Timothy Macdonald; Kevin R Lynch
Journal:  Am J Physiol Renal Physiol       Date:  2003-05-27

9.  Regulation of the Hippo-YAP pathway by G-protein-coupled receptor signaling.

Authors:  Fa-Xing Yu; Bin Zhao; Nattapon Panupinthu; Jenna L Jewell; Ian Lian; Lloyd H Wang; Jiagang Zhao; Haixin Yuan; Karen Tumaneng; Hairi Li; Xiang-Dong Fu; Gordon B Mills; Kun-Liang Guan
Journal:  Cell       Date:  2012-08-02       Impact factor: 41.582

Review 10.  Lysophospholipid growth factors and their G protein-coupled receptors in immunity, coronary artery disease, and cancer.

Authors:  Edward J Goetzl; Markus Graeler; Mei-Chuan Huang; Geetha Shankar
Journal:  ScientificWorldJournal       Date:  2002-02-06
View more
  13 in total

Review 1.  YAP/TAZ Signaling and Resistance to Cancer Therapy.

Authors:  Chan D K Nguyen; Chunling Yi
Journal:  Trends Cancer       Date:  2019-03-27

2.  ALDH2 deficiency promotes alcohol-associated liver cancer by activating oncogenic pathways via oxidized DNA-enriched extracellular vesicles.

Authors:  Wonhyo Seo; Yanhang Gao; Yong He; Jing Sun; Hongqin Xu; Dechun Feng; Seol Hee Park; Young-Eun Cho; Adrien Guillot; Tianyi Ren; Ruihong Wu; Jingyun Wang; Seung-Jin Kim; Seonghwan Hwang; Suthat Liangpunsakul; Yingzi Yang; Junqi Niu; Bin Gao
Journal:  J Hepatol       Date:  2019-07-04       Impact factor: 25.083

Review 3.  Emerging role of Hippo signalling pathway in bladder cancer.

Authors:  Jianling Xia; Ming Zeng; Hua Zhu; Xiangjian Chen; Zhiliang Weng; Shi Li
Journal:  J Cell Mol Med       Date:  2017-08-07       Impact factor: 5.310

4.  Mediated nuclear import and export of TAZ and the underlying molecular requirements.

Authors:  Michael Kofler; Pam Speight; Darby Little; Caterina Di Ciano-Oliveira; Katalin Szászi; András Kapus
Journal:  Nat Commun       Date:  2018-11-23       Impact factor: 14.919

5.  Yes-Associated Protein 1 as a Novel Prognostic Biomarker for Gastrointestinal Cancer: A Meta-Analysis.

Authors:  Luo Zhang; Xing Song; Xiaodong Li; Changping Wu; Jingting Jiang
Journal:  Biomed Res Int       Date:  2018-11-14       Impact factor: 3.411

6.  Thioredoxin Downregulation Enhances Sorafenib Effects in Hepatocarcinoma Cells.

Authors:  María José López-Grueso; Raúl González; Jordi Muntané; José Antonio Bárcena; C Alicia Padilla
Journal:  Antioxidants (Basel)       Date:  2019-10-22

7.  PGC-1α Controls Skeletal Stem Cell Fate and Bone-Fat Balance in Osteoporosis and Skeletal Aging by Inducing TAZ.

Authors:  Bo Yu; Lihong Huo; Yunsong Liu; Peng Deng; John Szymanski; Jiong Li; Xianghang Luo; Christine Hong; Jiandie Lin; Cun-Yu Wang
Journal:  Cell Stem Cell       Date:  2018-07-12       Impact factor: 25.269

8.  Cysteine residues are essential for dimerization of Hippo pathway components YAP2L and TAZ.

Authors:  Prem Khanal; Zongchao Jia; Xiaolong Yang
Journal:  Sci Rep       Date:  2018-02-22       Impact factor: 4.379

9.  Role of Clostridium perfringens Enterotoxin on YAP Activation in Colonic Sessile Serrated Adenoma/ Polyps with Dysplasia.

Authors:  Rina Fujiwara-Tani; Kiyomu Fujii; Shiori Mori; Shingo Kishi; Takamitsu Sasaki; Hitoshi Ohmori; Chie Nakashima; Isao Kawahara; Yukiko Nishiguchi; Takuya Mori; Masayuki Sho; Masuo Kondoh; Yi Luo; Hiroki Kuniyasu
Journal:  Int J Mol Sci       Date:  2020-05-28       Impact factor: 5.923

10.  A Therapeutic Silencing RNA Targeting Hepatocyte TAZ Prevents and Reverses Fibrosis in Nonalcoholic Steatohepatitis in Mice.

Authors:  Xiaobo Wang; Mark R Sommerfeld; Kerstin Jahn-Hofmann; Bishuang Cai; Aveline Filliol; Helen E Remotti; Robert F Schwabe; Aimo Kannt; Ira Tabas
Journal:  Hepatol Commun       Date:  2019-07-23
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.